Interestingly, in the literature, it is reported that E-cadherin and EpCAM genes are repressed by PRC2 [24,25], and, particularly, it has been found that in renal clear cell carcinomas and UTC, the EpCAM expression levels are associated with improved outcomes [24,26]. The gene discussed is EPCAM; the disease is clear cell renal carcinoma.